CVE-2023-38945

Public Exploit

Description

Multilaser RE160 v5.07.51_pt_MTL01 and v5.07.52_pt_MTL01, Multilaser RE160V v12.03.01.08_pt and V12.03.01.09_pt, and Multilaser RE163V v12.03.01.08_pt allows attackers to bypass the access control and gain complete access to the application via supplying a crafted URL.

Category

9.8
CVSS
Severity: Critical
CVSS 3.1 •
EPSS 0.04%
Third-Party Advisory seclists.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://seclists.org/fulldisclosure/2024/Mar/1 mailing list third party advisory exploit

Frequently Asked Questions

What is the severity of CVE-2023-38945?
CVE-2023-38945 has been scored as a critical severity vulnerability.
How to fix CVE-2023-38945?
To fix CVE-2023-38945, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-38945 being actively exploited in the wild?
It is possible that CVE-2023-38945 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.